TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26633188

Group type: EXPERIMENTAL
Intervention: Proportional Assist Ventilation (PAV)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Synchronized Intermittent Mandatory Ventilation (SIMV)
Number of subjects: 40
Study: 25035603

Group type: EXPERIMENTAL
Intervention: Yoga group (with standard medical treatment and yogic intervention)
Number of subjects: 241

Group type: COMPARATOR
Intervention: Control group (standard medical treatment without yogic intervention)
Number of subjects: 241
Study: 22181063

Group type: EXPERIMENTAL
Intervention: Insulin glargine (iGlar) with regular insulin (iReg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard intensive care unit protocol (St. Care)
Number of subjects: 20
Study: 20837925

Group type: EXPERIMENTAL
Intervention: OPCAB
Number of subjects: 308

Group type: COMPARATOR
Intervention: ONCAB
Number of subjects: 308
Study: 18811109

Group type: EXPERIMENTAL
Intervention: Photorefractive keratectomy (PRK)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Butterfly laser epithelial keratomileusis (butterfly LASEK)
Number of subjects: 51
Study: 12764986

Group type: EXPERIMENTAL
Intervention: Live Lactobacillus plantarum 299 (10^9 live bacteria) with oat fibre substrate, administered twice daily for 7 days.
Number of subjects: 45

Group type: COMPARATOR
Intervention: Heat-killed Lactobacillus plantarum 299, administered twice daily for 7 days.
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Live Lactobacillus plantarum 299 (treatment group)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Heat-killed Lactobacillus plantarum 299 (control group)
Number of subjects: 45
Study: 11070638

Group type: EXPERIMENTAL
Intervention: Brief clinician advice plus a 15-minute motivational counseling session
Number of subjects: 514

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 514
Study: 10021717

Group type: EXPERIMENTAL
Intervention: Prophylaxis with 200 mg/kg of porcine surfactant
Number of subjects: 93

Group type: COMPARATOR
Intervention: Routine assistance (control)
Number of subjects: 93
Study: 8418402

Group type: EXPERIMENTAL
Intervention: Emergency endoscopic retrograde cholangiopancreatography (ERCP) followed by endoscopic papillotomy within 24 hours of admission
Number of subjects: 195

Group type: COMPARATOR
Intervention: Conservative treatment and selective ERCP with or without endoscopic papillotomy
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Emergency ERCP with or without endoscopic papillotomy
Number of subjects: 195
Study: 3020960

Group type: EXPERIMENTAL
Intervention: Calcium carbonate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium lactate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium gluconate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Orange juice (as carrier)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Milk (as carrier)
Number of subjects: 0
Study: 31315446

Group type: EXPERIMENTAL
Intervention: Monthly telemedical consultations in addition to regular care
Number of subjects: 240

Group type: COMPARATOR
Intervention: Regular care (waiting control group)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Qualitative interviews
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Health-economic analysis
Number of subjects: 240
Study: 29573247

Group type: EXPERIMENTAL
Intervention: Quadrivalent Influenza Vaccine (GC3110A)
Number of subjects: 528

Group type: COMPARATOR
Intervention: Trivalent Influenza Vaccine (Control)
Number of subjects: 528
Study: 27031953

Group type: EXPERIMENTAL
Intervention: Bladder stimulation technique
Number of subjects: 142
Study: 24733354

Group type: EXPERIMENTAL
Intervention: Direct-to-consumer educational intervention
Number of subjects: 303

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 303
Study: 21596578

Group type: EXPERIMENTAL
Intervention: Bupivacaine (1.5 mg kg(‐1) via paravertebral subpleural catheter for 3 days)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Morphine (0.2 mg kg(‐1) via paravertebral subpleural catheter for 3 days)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (tramadol 100 mg plus metamizol 1000 mg intravenously every 4 h for 3 days)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Bupivacaine
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 45
Study: 20438942

Group type: EXPERIMENTAL
Intervention: Hyperthermic intraperitoneal chemotherapy (HIPEC)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Chemotherapy +/- radiation therapy or surgery alone (historical controls)
Number of subjects: 24
Study: 18641716

Group type: EXPERIMENTAL
Intervention: Plant sterol (PS) intervention
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control phase
Number of subjects: 26
Study: 15810771

Group type: EXPERIMENTAL
Intervention: Whole practice group (practiced all four components together)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: No Overlap group (practiced first two and last two components, alternating every fifth trial)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overlap group (practiced transition between second and third components, alternating first three and last three components every five trials)
Number of subjects: 0
Study: 12859465

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 67
Study: 10100253

Group type: COMPARATOR
Intervention: brimonidine 0.2%
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: apraclonidine 0.5%
Number of subjects: 85
Study: 8724923

Group type: EXPERIMENTAL
Intervention: KR on every trial
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Summary KR
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Average KR
Number of subjects: 51

Group type: COMPARATOR
Intervention: No KR
Number of subjects: 51
Study: 1725148

Group type: EXPERIMENTAL
Intervention: Cefixime 400mg
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Ofloxacin 200mg
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Cotrimoxazole 160/800mg
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123
Study: 6336952

Group type: EXPERIMENTAL
Intervention: 3% acyclovir and 0.01% betamethasone drops
Number of subjects: 40

Group type: COMPARATOR
Intervention: Acyclovir alone
Number of subjects: 40
Study: 31776915

Group type: EXPERIMENTAL
Intervention: Haemodynamic monitoring with CardioMEMS PA sensor
Number of subjects: 340

Group type: COMPARATOR
Intervention: Standard HF care alone
Number of subjects: 340
Study: 30878487

Group type: EXPERIMENTAL
Intervention: rAAV.sFLT-1 gene therapy (GT)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 37
Study: 27567022

Group type: EXPERIMENTAL
Intervention: Radial extracorporeal shock wave treatment (rESWT) - two sessions, 2,000 shock waves per session, energy flux density of 0.16 mJ/mm2
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Radial extracorporeal shock wave treatment (rESWT)
Number of subjects: 50
Study: 26639151

Group type: EXPERIMENTAL
Intervention: Leaf concentrate powder (LCP) 10 g daily
Number of subjects: 83

Group type: COMPARATOR
Intervention: Skimmed milk powder (SMP) 15 g daily
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Leaf concentrate powder (LCP)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Skimmed milk powder (SMP)
Number of subjects: 83
Study: 25134956

Group type: EXPERIMENTAL
Intervention: Solid-head power toothbrush
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hollow-head power toothbrush 1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hollow-head power toothbrush 2
Number of subjects: 0
Study: 22641493

Group type: EXPERIMENTAL
Intervention: 12-core biopsy
Number of subjects: 474

Group type: COMPARATOR
Intervention: 10-core biopsy
Number of subjects: 474
Study: 18952469

Group type: EXPERIMENTAL
Intervention: Self-help intervention
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Face-to-face treatments
Number of subjects: 1000
Study: 17501954

Group type: EXPERIMENTAL
Intervention: ALA-PDT
Number of subjects: 16

Group type: COMPARATOR
Intervention: MAL-PDT
Number of subjects: 16
Study: 15327047

Group type: EXPERIMENTAL
Intervention: 4-aminopyridine (4-AP) 24 mg/day
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: fluoxetine (FLX) 20 mg/day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (placebo effect implied)
Number of subjects: 60
Study: 11346221

Group type: EXPERIMENTAL
Intervention: Meloxicam 7.5 mg daily for 4 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Piroxicam 20 mg daily for 4 weeks
Number of subjects: 0
Study: 9222189

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type B (BTXB)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Botulinum toxin type A (BTXA)
Number of subjects: 17
Study: 8431908

Group type: EXPERIMENTAL
Intervention: Hydroxyurea
Number of subjects: 0

Group type: COMPARATOR
Intervention: Misonidazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cisplatin with infusional 5-fluorouracil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Concurrent chemotherapy with extended field radiation
Number of subjects: 0
Study: 3631918

Group type: EXPERIMENTAL
Intervention: Scopolamine (0.25 mg)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control (no scopolamine)
Number of subjects: 64
Study: 30016516

Group type: EXPERIMENTAL
Intervention: Iron-biofortified pearl millet (Fe = 86 ppm)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Conventional pearl millet (Fe = 21-52 ppm)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Iron-biofortified pearl millet
Number of subjects: 140

Group type: COMPARATOR
Intervention: Conventional pearl millet
Number of subjects: 140
Study: 26915374

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan 97/103 mg twice daily
Number of subjects: 8399

Group type: COMPARATOR
Intervention: Enalapril 10 mg twice daily
Number of subjects: 8399
Study: 25321314

Group type: EXPERIMENTAL
Intervention: KinFact intervention
Number of subjects: 490

Group type: COMPARATOR
Intervention: Control handout
Number of subjects: 490
Study: 22468766

Group type: EXPERIMENTAL
Intervention: Fructose + maltodextrin solution
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Fructose + maltodextrin solution (adjusted for gastrointestinal discomfort)
Number of subjects: 26
Study: 20429674

Group type: EXPERIMENTAL
Intervention: 12-month physical activity counselling programme
Number of subjects: 347

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 347
Study: 18463957

Group type: EXPERIMENTAL
Intervention: D2 gastrectomy
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: D4 gastrectomy
Number of subjects: 269

Group type: COMPARATOR
Intervention: D2 vs D4 comparison
Number of subjects: 269
Study: 16248240

Group type: COMPARATOR
Intervention: Diane-35 in the Western medicine group (WMG)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Conventional controlled medicine plus modified Yougui Pill in the integrative medicine group (IMG)
Number of subjects: 63
Study: 12573751

Group type: EXPERIMENTAL
Intervention: Postmastectomy irradiation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Older trials not guided by well-developed guidelines
Number of subjects: 0
Study: 15022968

Group type: EXPERIMENTAL
Intervention: Cochrane Library systematic reviews relevant to pain management and palliative care
Number of subjects: 10

Group type: COMPARATOR
Intervention: Cochrane Library systematic reviews
Number of subjects: 10
Study: 9607357

Group type: EXPERIMENTAL
Intervention: Radiotherapy, 12 courses of cyclophosphamide, methotrexate, and 5‐fluorouracil (CMF), and tamoxifen (arm II)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Adriamycine, vincristine (AV) alternated with CMF, then radiotherapy, followed by four cycles of chemotherapy (AV/CMF); and tamoxifen during the entire treatment period (arm III)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Radiotherapy alone (arm I)
Number of subjects: 118
Study: 7617803

Group type: EXPERIMENTAL
Intervention: Nicotine (20 micrograms/kg) administered 30 min before challenge
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Nicotine (20 micrograms/kg) administered 60 min before challenge
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Nicotine (20 micrograms/kg) administered 120 min before challenge
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo administered 30 min before challenge
Number of subjects: 16
Study: 2197538

Group type: EXPERIMENTAL
Intervention: Azidothymidine plus aerosolized pentamidine
Number of subjects: 27

Group type: COMPARATOR
Intervention: Azidothymidine alone
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Pentamidine aerosol
Number of subjects: 27
Study: 65196

Group type: EXPERIMENTAL
Intervention: Candicidin (300 mg daily dose, 6 capsules per day)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 62
Study: 31532589

Group type: EXPERIMENTAL
Intervention: Tenoten (10 drops per day)
Number of subjects: 184
Study: 28466585

Group type: EXPERIMENTAL
Intervention: Tamsulosin, dutasteride and imidafenacin
Number of subjects: 163

Group type: COMPARATOR
Intervention: Tamsulosin and dutasteride
Number of subjects: 163
Study: 25446217

Group type: EXPERIMENTAL
Intervention: High-MUFA meal
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: High-SFA meal
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: High-PUFA meal
Number of subjects: 16
Study: 23828184

Group type: EXPERIMENTAL
Intervention: Massage therapy
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Combined massage-exercise therapy
Number of subjects: 48

Group type: COMPARATOR
Intervention: Exercise therapy
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (standard medical care)
Number of subjects: 48
Study: 21216512

Group type: EXPERIMENTAL
Intervention: Topical polyantibiotic ointment application at CVC exit sites (1 time/week)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical polyantibiotic ointment application at CVC exit sites
Number of subjects: 0
Study: 18989889

Group type: EXPERIMENTAL
Intervention: Paclitaxel at 250 mg/m2
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Paclitaxel at 325 mg/m2
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Paclitaxel at 425 mg/m2
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Paclitaxel at 550 mg/m2
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Combination of paclitaxel and ifosfamide
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Paclitaxel (MTD)
Number of subjects: 15
Study: 16888407

Group type: EXPERIMENTAL
Intervention: Proton beam radiotherapy followed by transpupillary thermotherapy (TTT) at 1, 6, and 12 months
Number of subjects: 151

Group type: COMPARATOR
Intervention: Proton beam radiotherapy alone (60 Gy in 4 fractions)
Number of subjects: 151
Study: 15282382

Group type: EXPERIMENTAL
Intervention: Asthma attacks in the last 12 months
Number of subjects: 11168

Group type: EXPERIMENTAL
Intervention: Asthma medication usage
Number of subjects: 11168

Group type: COMPARATOR
Intervention: Reported symptoms of asthma
Number of subjects: 11168

Group type: EXPERIMENTAL
Intervention: Nasal allergies
Number of subjects: 11168
Study: 11347287

Group type: COMPARATOR
Intervention: Chlorella supplementation (10 g in tablet form and 100 mL liquid extract daily for 2 or 3 months)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Chlorella supplementation
Number of subjects: 97
Study: 9272481

Group type: EXPERIMENTAL
Intervention: Ketamine (subanesthetic doses)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 8499051

Group type: EXPERIMENTAL
Intervention: Phenobarbital
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3693583

Group type: EXPERIMENTAL
Intervention: Long-acting propranolol 160 mg/d
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Conventional propranolol 40 mg qid
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 31093503

Group type: EXPERIMENTAL
Intervention: Multispecies probiotic supplementation (F1 and F2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (F3)
Number of subjects: 0
Study: 28377360

Group type: EXPERIMENTAL
Intervention: Shangbai ointment treatment
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study: 25308350

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin administration
Number of subjects: 0
Study: 24092872

Group type: EXPERIMENTAL
Intervention: Prednisolone (2 mg/kg/d for 3 days)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Dexamethasone (0.6 mg/kg, 1 dose)
Number of subjects: 87
Study: 20718826

Group type: EXPERIMENTAL
Intervention: Pre-operative dietary restriction (30% calorie-restricted diet followed by one day of water-only fasting)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Ad libitum intake (control group)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Pre-operative dietary restriction
Number of subjects: 30
Study: 19683043

Group type: EXPERIMENTAL
Intervention: 12.6% Ageratina pichinchensis extract
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: 16.8% Ageratina pichinchensis extract
Number of subjects: 122
Study: 17339866

Group type: EXPERIMENTAL
Intervention: Short-acting inhaler beta2 mimetic as required + 800 mug inhaler budesonide + leukotriene receptor antagonist
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Short-acting inhaler beta2 mimetic as required + 800 mug inhaler budesonide
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Short-acting inhaler beta2 mimetic as required + 800 mug inhaler budesonide + vitamin E
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (10 healthy volunteers)
Number of subjects: 31
Study: 15076943

Group type: EXPERIMENTAL
Intervention: Ganciclovir implant plus oral ganciclovir
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: General anesthesia and inpatient surgery
Number of subjects: 42

Group type: COMPARATOR
Intervention: Local anesthesia and outpatient surgery
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 42
Study: 11790415

Group type: EXPERIMENTAL
Intervention: Thicker shake (high viscosity)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Thinner shake (low viscosity)
Number of subjects: 84
Study: 9744203

Group type: EXPERIMENTAL
Intervention: Focus group discussions with women in the community
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Focus group discussions with breast cancer patients
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Focus group discussions with both groups
Number of subjects: 41
Study: 7977879

Group type: EXPERIMENTAL
Intervention: Combined nortriptyline and interpersonal psychotherapy
Number of subjects: 32
Study: 2658142

Group type: EXPERIMENTAL
Intervention: Mifepristone 400 mg/d
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 1103724

Group type: EXPERIMENTAL
Intervention: Variable Frequency Regimen (VFR)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Variable Dosage Regimen (VDR)
Number of subjects: 20
Study: 31996709

Group type: EXPERIMENTAL
Intervention: Home-based cognitive training (Lumosity Cognitive Training) for 8 weeks, 5 sessions per week (40 sessions)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Waiting-list control group (Waiting-first Group)
Number of subjects: 2
Study: 31518044

Group type: EXPERIMENTAL
Intervention: Aged garlic extract (AGE) 2400 mg daily for 1 year
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study: 28526467

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided transversus abdominis plane block (UT group; n=38)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Surgical transversus abdominis plane block (ST group; n=37)
Number of subjects: 75
Study: 25114123

Group type: EXPERIMENTAL
Intervention: Fixed appliance with multi-brackets
Number of subjects: 62

Group type: COMPARATOR
Intervention: Removable appliance with protruding springs
Number of subjects: 62
Study: 23051178

Group type: EXPERIMENTAL
Intervention: Gut-directed hypnotherapy (1 hour per week for 12 weeks)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Gut-directed hypnotherapy
Number of subjects: 83
Study: 22000914

Group type: EXPERIMENTAL
Intervention: Phone calls from specialized social workers
Number of subjects: 131

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 131
Study: 22436099

Group type: EXPERIMENTAL
Intervention: 10 mg of nifedipine with 480 mg of curcuminoid (6 tablets of turmeric extract)
Number of subjects: 10

Group type: COMPARATOR
Intervention: 10 mg of nifedipine (control)
Number of subjects: 10
Study: 17302248

Group type: EXPERIMENTAL
Intervention: Genotypic resistance testing (Virtual Phenotype)
Number of subjects: 170

Group type: COMPARATOR
Intervention: No testing
Number of subjects: 170
Study: 12937334

Group type: EXPERIMENTAL
Intervention: Automated interactive voice response (IVR) intervention for caregivers, yearlong access.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care control group.
Number of subjects: 100
Study: 10729390

Group type: EXPERIMENTAL
Intervention: LPL gene analysis
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: HTGL gene analysis
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ser267Phe mutation
Number of subjects: 20
Study: 9013080

Group type: EXPERIMENTAL
Intervention: 17 beta‐oestradiol and norethisterone acetate (intervention group)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo capsules (control group)
Number of subjects: 28
Study: 1521049

Group type: EXPERIMENTAL
Intervention: Cigarette yield, consumption, self-reported inhalation, and puffing characteristics under standardized smoking conditions (30 puffs through a holder)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Cigarette yield, consumption, self-reported inhalation, and puffing characteristics under natural smoking conditions
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Cigarette yield, consumption, self-reported inhalation, and puffing characteristics
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Standardized smoking conditions (30 puffs through a holder)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Natural smoking conditions
Number of subjects: 144
Study: 3156805

Group type: EXPERIMENTAL
Intervention: 2 g spectinomycin
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: 250 mg ceftriaxone
Number of subjects: 200
Study: 31870458

Group type: EXPERIMENTAL
Intervention: Body acupressure
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Auricular acupressure
Number of subjects: 90

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 90